- Home
- ZENV vs SER Comparison
ZENV vs SER Comparison
Compare ZENV & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZENV | SER |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.8M | 42.0M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ZENV | SER |
|---|---|---|
| Price | $1.25 | $3.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 27.4K | 14.5K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $201,426,369.00 | $116,000.00 |
| Revenue This Year | $12.75 | $134.46 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.80 | N/A |
| 52 Week Low | $1.02 | $3.14 |
| 52 Week High | $3.03 | $7.92 |
Technical Indicators
Market Signals| Indicator | ZENV | SER |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 29.79 |
| Support Level | $1.13 | $3.15 |
| Resistance Level | $1.27 | $4.26 |
| Average True Range (ATR) | 0.07 | 0.25 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 76.52 | 0.09 |
Price Performance
Historical ComparisonAbout ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.